The cell culture market is expected to grow at a CAGR of 13% during the forecast period. Increase in infectious diseases, drivers.2, and drivers.3 are some of the significant factors fueling cell culture market growth.
Increase in infectious diseases
The consumables used in cell culture include sera, media, and reagents. The sera include adult bovine sera (ABS), fetal bovine sera (FBS), and other animal sera. The media includes serum-free media, stem cell media, specialty media, and classical media and salts. The reagents include supplements, growth factors, cell dissociation reagents, contamination detection kits, antibiotics, antimycotics, cell culture reagents, salt solutions, buffers, and other accessories.
High availability and vast applicability, along with repeated usage, make the consumables segment the largest segment in terms of revenue in the global cell culture market. Low price is another key driving factor for the high adoption of consumables, which are sold along with compatible instruments at a lower price than when they are bought separately.
The increasing diseased population is triggering the need for cell culture-based products, thus increasing the demand for consumables. For instance, Humulin is a cell culture-based product that is now widely used to treat patients who have diabetes globally. The rising number of diabetic patients is likely to increase the demand for Humulin, which in turn will increase the demand for consumables and benefit the market.
Owing to the growing cell-based research and the increasing demand for cell-based therapies, vendors are investing in R&D to develop cell media, reagents, and supplements. For instance, in September 2019, FUJIFILM Irvine Scientific Inc., a subsidiary of FUJIFILM Holdings Corp., introduced BalanCD Gal Supplement that is used to increase galactosylation in biotherapeutic development, which would help to achieve desired glycan profiles for improved product quality and antibody efficacy. Therefore, the availability of such products will contribute to the growth of the consumables segment in the global cell culture market during the forecast period.
